[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100559072":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":11,"centralContacts":16,"locations":21,"responsibleParty":41,"collaborators":10,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":10,"eligibilityCriteria":50,"healthyVolunteers":47,"sex":51,"minAge":52,"maxAge":10,"enrollmentInfo":53,"targetDuration":10,"studyType":56,"phases":10,"briefSummary":57,"conditions":58,"keywords":61,"overallStatus":24,"whyStopped":10,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},{"fullName":5,"class":6},"Shanghai Jiao Tong University School of Medicine","OTHER",[8],{"label":9,"type":10,"description":9,"interventionNames":10},"68Ga-FAPI PET\u002FCT",null,[12],{"name":13,"affiliation":14,"role":15},"Xiaosong Chen","Shanghai Jiao Tong University, School of Medicine, Affiliated Ruijin Hospital","PRINCIPAL_INVESTIGATOR",[17],{"name":13,"role":18,"phone":19,"phoneExt":10,"email":20},"CONTACT","86-21-64370045","zsj_mu@yeah.net",[22],{"facility":23,"status":24,"city":25,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"Shanghai Jiao Tong University School of Medicine, Ruijin Hospital","RECRUITING","Shanghai","Shanghai Municipality","200020","China","CN",{"type":31,"coordinates":32},"Point",[33,34],121.45806,31.22222,{"lat":34,"lon":33},[37],{"name":38,"role":18,"phone":39,"phoneExt":10,"email":40},"Chao Hu, M.D. & Ph.D.","+86 13817282551","chaohu1988@hotmail.com",{"type":42,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Kunwei Shen","Professor","100559072","68ga-fapi-petct-evaluation-of-axillary-lymph-node-status-after-neoadjuvant-therapy-in-patients-with-clinical-axillary-lymph-node-positive-breast-cancer-100559072",false,"NCT06559371","68Ga FAPI PET\u002FCT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer","Inclusion Criteria:\n\n* Female patients aged 18 and above\n* ECOG score 0-2 points\n* Pathological confirmation of malignant breast tumor\n* Clinical axillary lymph node positivity (cN+)\n* Completed at least 3 courses of neoadjuvant therapy and subjected to undergo surgical treatment\n* Informed consent form signed\n\nExclusion Criteria:\n\n* Distant metastasis\n* Unable to complete the proposed neoadjuvant therapy plan\n* Pregnancy","FEMALE","18 Years",{"count":54,"type":55},150,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to learn whether 68Ga-FAPI PET\u002FCT may be used as a new effective methods for evaluating axillary lymph node efficacy after neoadjuvant treatment for breast cancer. The main question it aims to answer is:\n\nCould 68Ga-FAPI PET\u002FCT effectively evaluate axillary lymph node after neoadjuvant treatment for breast cancer? Participants will have a 68Ga-FAPI PET\u002FCT test between last neoadjuvant therapy and surgery.",[59,60],"BREAST CANCER","PET\u002FCT",[59,60],"2025-12-21",{"date":64,"type":65},"2025-12-29","ACTUAL",{"date":67,"type":65},"2024-08-30",{"date":69,"type":55},"2026-06-30",{"name":43,"class":6},1]